From a valuation perspective, UNH appears expensive compared to its peers despite the drop in price.
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UnitedHealth Group spent nearly $1.7 million on security for its top executives in 2024, the healthcare conglomerate disclosed on Monday, months after the fatal shooting of senior executive Brian Thompson outside a Manhattan hotel in December.
UnitedHealth Group Inc. NYSE: UNH is a bellwether for the health insurance industry. The company symbolized the flaws in managed care organizations (MCOs) in the medical sector after its United Healthcare CEO was assassinated in December 2024.
UnitedHealth Group spent nearly $1.7 million on security for its top executives in 2024, the healthcare conglomerate disclosed on Monday, months after the fatal shooting of senior executive Brian Thompson outside a Manhattan hotel in December.
UnitedHealth Group's management team is the best-in-class. The data proves it. Current operational, financial and regulatory challenges represent near-term issues versus long-term industry fundamental deterioration. Despite rhetoric otherwise, the large health insurers remain the only viable game in town. The stock post-earnings valuation appears attractive. In one day, Mr. Market knocked about $120 billion off the market cap. My updated FVE is ~$525 versus a current ~$435 bid.
UnitedHealth's worst drop in 25 years following dismal earnings presents an opportunity for investors to buy the stock with ETFs.
UnitedHealth's latest earnings miss was almost entirely due to Medicare Advantage trends, analysts say.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UnitedHealth's recent stock drop is an overreaction to Q1 2025 earnings and outlook, presenting a strategic long-term buying opportunity. UNH's strong financials, including increased net income, free cash flow, and dividends, support its resilience and growth potential. Despite negative sentiment and market risks, historical data shows UNH's consistent recovery and higher trading levels after significant drops.
UnitedHealth's 20% steep collapse unveils the challenges afflicting the company, as it navigates a troubling recovery phase. Still, investors shouldn't downplay its well-diversified business, providing much-needed resilience as compared to peers. President Trump's executive order to review the healthcare value chain could have ramifications on UNH's recovery. But, too early to call.
Here are some of the major companies whose stocks moved on the week's news